News stories about Vascular Solutions (NASDAQ:VASC) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vascular Solutions earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave media coverage about the medical device company an impact score of 45.3472842725256 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Vascular Solutions (VASC) remained flat at $56.00 during trading on Monday. The company’s 50-day moving average is $55.89 and its 200-day moving average is $51.22. Vascular Solutions has a 12-month low of $25.06 and a 12-month high of $57.15.
About Vascular Solutions
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with our FREE daily email newsletter.